Drug Information

Drug General Information
Drug ID
D0R1JM
Former ID
DNCL002999
Drug Name
NRT inhibitor
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 2 [550383]
Company
Bristol-Myers Squibb
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Inhibitor [530457]
References
Ref 550383Pipeline report of Bristol-Myers Squibb in August 2013.
Ref 530457Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor. J Biol Chem. 2009 Dec 18;284(51):35681-91.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.